Procept (PRCT): 50% rise on high volume. Why? Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Procept (PRCT): 50% rise on high volume. Why?

PRCT 30.93

-3.1%

Nov 10 3:59 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Douglas who wrote (165)	5/12/1997 12:59:00 PM
From: Gerald Thomas	of 455

As we ended 1995, PRO 2000, a compound that blocks infection of T cells by HIV, was being evaluated as an injectable drug to reduce the level of virus found in patients. The results of that trial indicated that we would be limited in the amound of drug that we could inject. An innovative solution developed by our scientists was to reformulate this drug into a gel that could be used by women intravaginaly to prevent transmission of HIV and other sexually transmitted diseasses such as herpes. My take on that is that higher levels of injected pro-2000 caused problems and would be necessary to effect the necessary results... Finally SOME closure on the systemic trial (several months late...) My speculation is that there were some positive results but higher doses were a problem... Could bode well for topical trial .....

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next